21154

540596

ERIS

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

ERIS LIFESCIENCES LIMITED Share Price Today

ERIS LIFESCIENCES LIMITED is currently trading at ₹1401, up by ₹35.4 from the previous close. The stock touched an intraday high of ₹1411.40 and a low of ₹1365.30 during the latest trading session. Over the past one year, ERIS LIFESCIENCES LIMITED has delivered a loss of 20.38%, while the stock has declined 0.78% in the last one month.

ERIS LIFESCIENCES LIMITED performance

Today’s low Today’s high
₹ 1365.30 ₹ 1411.40
₹ 1404.60
52 week low 52 week high
₹ 1200.00 ₹ 1910.00
₹ 1404.60
Open Price ₹ 1388.00
Prev. Close ₹ 1365.60
Volume (Shares) 63719.00
Total traded value ₹ 894.99
Upper Circuit ₹ 1638.70
Lower Circuit ₹ 1092.50
info

Investment Returns

Over 1 Month -0.78% Over 3 Months 1.20% Over 6 Months -14.14% Over 1 Year -20.38%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

ERIS LIFESCIENCES LIMITED fundamentals


  • Market cap (Cr) 19,463.20
  • P/E Ratio (TTM) 79.66
  • Beta 0.53
  • Book Value / share 230.60
  • Return on equity 3.07%
  • EPS (TTM) 18.33
  • Dividend yield 0.51%
  • Net profit/quarter (Cr) -8.60
info icon alternate text
  • Market cap (Cr) 19,439.60
  • P/E Ratio (TTM) 79.66
  • Beta 0.51
  • Book Value / share 230.60
  • Return on equity 3.07%
  • EPS (TTM) 18.33
  • Dividend yield 0.51%
  • Net profit/quarter (Cr) -8.60
info icon alternate text

ERIS LIFESCIENCES LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 267.52
Operating Expense 337.05
Net Profit -8.60
Net Profit Margin (%) -3.21
Earnings Per Share (EPS) -0.63
EBITDA 48.75
Effective Tax Rate (%) 73.75
Particulars DEC 2025 (Values in Cr)
Revenue 306.78
Operating Expense 321.80
Net Profit 3.09
Net Profit Margin (%) 1.00
Earnings Per Share (EPS) 0.23
EBITDA 87.75
Effective Tax Rate (%) 20.56
Particulars SEP 2025 (Values in Cr)
Revenue 637.58
Operating Expense 439.42
Net Profit 149.57
Net Profit Margin (%) 23.45
Earnings Per Share (EPS) 10.98
EBITDA 320.46
Effective Tax Rate (%) 36.26
Particulars JUN 2025 (Values in Cr)
Revenue 567.90
Operating Expense 445.06
Net Profit 99.99
Net Profit Margin (%) 17.60
Earnings Per Share (EPS) 7.34
EBITDA 238.99
Effective Tax Rate (%) 36.01
Particulars MAR 2025 (Values in Cr)
Revenue 395.71
Operating Expense 380.34
Net Profit 30.47
Net Profit Margin (%) 7.70
Earnings Per Share (EPS) 2.24
EBITDA 137.72
Effective Tax Rate (%) 26.00
Particulars MAR 2026 (Values in Cr)
Revenue 1779.77
Operating Expense 1543.33
Net Profit 244.05
Net Profit Margin (%) 13.71
Earnings Per Share (EPS) 17.86
EBITDA 695.97
Effective Tax Rate (%) 32.59
Particulars MAR 2025 (Values in Cr)
Revenue 1663.63
Operating Expense 1613.21
Net Profit 77.39
Net Profit Margin (%) 4.65
Earnings Per Share (EPS) 5.69
EBITDA 522.06
Effective Tax Rate (%) 35.53
Particulars MAR 2024 (Values in Cr)
Revenue 1454.75
Operating Expense 1192.70
Net Profit 299.72
Net Profit Margin (%) 20.60
Earnings Per Share (EPS) 22.04
EBITDA 488.65
Effective Tax Rate (%) 8.85
Particulars MAR 2023 (Values in Cr)
Revenue 1307.12
Operating Expense 911.07
Net Profit 398.01
Net Profit Margin (%) 30.44
Earnings Per Share (EPS) 29.27
EBITDA 522.38
Effective Tax Rate (%) 8.90
Particulars MAR 2022 (Values in Cr)
Revenue 1193.77
Operating Expense 786.18
Net Profit 417.19
Net Profit Margin (%) 34.94
Earnings Per Share (EPS) 30.70
EBITDA 512.99
Effective Tax Rate (%) 9.01
Particulars MAR 2025 (Values in Cr)
Book Value / Share 209.57
ROE % 13.77
ROCE % 13.29
Total Debt to Total Equity 0.97
EBITDA Margin 35.61
Particulars MAR 2024 (Values in Cr)
Book Value / Share 190.16
ROE % 16.61
ROCE % 12.06
Total Debt to Total Equity 0.76
EBITDA Margin 33.98
Particulars MAR 2023 (Values in Cr)
Book Value / Share 161.48
ROE % 18.23
ROCE % 16.68
Total Debt to Total Equity 0.23
EBITDA Margin 31.62
Particulars MAR 2022 (Values in Cr)
Book Value / Share 140.36
ROE % 23.29
ROCE % 24.45
Total Debt to Total Equity 0.03
EBITDA Margin 37.94
Particulars MAR 2021 (Values in Cr)
Book Value / Share 116.10
ROE % 24.72
ROCE % 26.81
Total Debt to Total Equity 0.00
EBITDA Margin 36.26
Particulars MAR 2025 (Values in Cr)
Book Value / Share 184.65
ROE % 3.07
ROCE % 6.83
Total Debt to Total Equity 0.96
EBITDA Margin 30.64
Particulars MAR 2024 (Values in Cr)
Book Value / Share 185.59
ROE % 12.63
ROCE % 9.97
Total Debt to Total Equity 0.61
EBITDA Margin 31.97
Particulars MAR 2023 (Values in Cr)
Book Value / Share 163.39
ROE % 19.23
ROCE % 19.94
Total Debt to Total Equity 0.08
EBITDA Margin 38.97
Particulars MAR 2022 (Values in Cr)
Book Value / Share 141.11
ROE % 23.88
ROCE % 25.68
Total Debt to Total Equity 0.00
EBITDA Margin 42.20
Particulars MAR 2021 (Values in Cr)
Book Value / Share 116.03
ROE % 24.39
ROCE % 26.48
Total Debt to Total Equity 0.00
EBITDA Margin 38.55
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 222.83
Total Assets 7033.17
Total Liabilities 7033.17
Total Equity 3271.76
Share Outstanding 13
Price to Book Ratio 7.67
Return on Assets (%) 5.00
Return on Capital (%) 6.18
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1400.64
Total Assets 7040.46
Total Liabilities 7040.46
Total Equity 3222.09
Share Outstanding 13
Price to Book Ratio 4.53
Return on Assets (%) 5.56
Return on Capital (%) 6.58
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 58.45
Total Assets 3667.32
Total Liabilities 3667.32
Total Equity 2220.67
Share Outstanding 13
Price to Book Ratio 3.50
Return on Assets (%) 10.42
Return on Capital (%) 12.53
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 52.32
Total Assets 2272.13
Total Liabilities 2272.13
Total Equity 1908.20
Share Outstanding 13
Price to Book Ratio 4.88
Return on Assets (%) 17.87
Return on Capital (%) 20.79
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 38.27
Total Assets 1834.78
Total Liabilities 1834.78
Total Equity 1576.42
Share Outstanding 13
Price to Book Ratio 5.21
Return on Assets (%) 19.35
Return on Capital (%) 22.53
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 92.46
Total Assets 5222.43
Total Liabilities 5222.43
Total Equity 2514.90
Share Outstanding 13
Price to Book Ratio 7.67
Return on Assets (%) 1.48
Return on Capital (%) 1.64
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1296.73
Total Assets 5349.57
Total Liabilities 5349.57
Total Equity 2524.02
Share Outstanding 13
Price to Book Ratio 4.53
Return on Assets (%) 5.60
Return on Capital (%) 5.93
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 47.64
Total Assets 2783.65
Total Liabilities 2783.65
Total Equity 2221.88
Share Outstanding 13
Price to Book Ratio 3.50
Return on Assets (%) 14.29
Return on Capital (%) 15.68
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 46.10
Total Assets 2150.41
Total Liabilities 2150.41
Total Equity 1918.55
Share Outstanding 13
Price to Book Ratio 4.88
Return on Assets (%) 19.40
Return on Capital (%) 21.75
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 32.65
Total Assets 1754.80
Total Liabilities 1754.80
Total Equity 1575.46
Share Outstanding 13
Price to Book Ratio 5.21
Return on Assets (%) 19.97
Return on Capital (%) 22.25
Particulars MAR 2025 (Values in Cr)
Net Income 488.87
Cash from Operations 1162.89
Cash from Investing -79.97
Cash from Financing -881.32
Net change in Cash 103.72
Free Cash Flow 1317.89
Particulars MAR 2024 (Values in Cr)
Net Income 431.34
Cash from Operations 586.76
Cash from Investing -1854.52
Cash from Financing 1379.78
Net change in Cash 11.27
Free Cash Flow 715.92
Particulars MAR 2023 (Values in Cr)
Net Income 404.64
Cash from Operations 368.94
Cash from Investing -982.10
Cash from Financing 688.02
Net change in Cash -2.33
Free Cash Flow 1210.36
Particulars MAR 2022 (Values in Cr)
Net Income 442.19
Cash from Operations 461.54
Cash from Investing -319.61
Cash from Financing -44.69
Net change in Cash 13.95
Free Cash Flow 582.58
Particulars MAR 2021 (Values in Cr)
Net Income 394.49
Cash from Operations 443.89
Cash from Investing -323.35
Cash from Financing -82.39
Net change in Cash -30.39
Free Cash Flow 469.65
Particulars MAR 2025 (Values in Cr)
Net Income 120.05
Cash from Operations 715.30
Cash from Investing -358.99
Cash from Financing -310.46
Net change in Cash 32.41
Free Cash Flow 722.92
Particulars MAR 2024 (Values in Cr)
Net Income 328.83
Cash from Operations 409.77
Cash from Investing -2491.89
Cash from Financing 2160.05
Net change in Cash 4.45
Free Cash Flow 758.81
Particulars MAR 2023 (Values in Cr)
Net Income 436.91
Cash from Operations 400.11
Cash from Investing -513.29
Cash from Financing 193.74
Net change in Cash 2.77
Free Cash Flow 711.37
Particulars MAR 2022 (Values in Cr)
Net Income 458.53
Cash from Operations 452.31
Cash from Investing -267.63
Cash from Financing -88.42
Net change in Cash 13.35
Free Cash Flow 505.59
Particulars MAR 2021 (Values in Cr)
Net Income 388.89
Cash from Operations 463.44
Cash from Investing -347.86
Cash from Financing -81.12
Net change in Cash -33.58
Free Cash Flow 489.06
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.52 13.02 1.52 241.55 23.12 38.85
BLISS GVS PHARMA LTD. 436.05 35.28 3.86 4612.93 118.35 462.70
CIPLA LTD 1383.00 29.35 3.24 111725.01 1165.55 1672.20
FERMENTA BIOTECH LTD. 328.55 14.49 2.37 966.96 256.40 399.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.52 22.04 4.06 241.55 23.12 38.85
AMRUTAJAN HEALTH LTD 562.65 25.22 4.39 1626.66 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8248.80 107.73 23.62 20622.00 7630.00 10653.05
BLISS GVS PHARMA LTD. 436.05 46.89 3.99 4612.93 118.35 462.70

ERIS LIFESCIENCES LIMITED shareholding pattern

Holding
19.32%
53.92%
6.39%
20.35%
16.92%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

ERIS LIFESCIENCES LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
1404.60 2.85 redarrow
red-green-graph indicator
1 Bearish
15 Bullish
  • 5 Days 1380.30
  • 26 Days 1371.30
  • 10 Days 1375.90
  • 50 Days 1371.70
  • 12 Days 1375.00
  • 100 Days 1396.60
  • 20 Days 1372.60
  • 200 Days 1439.40
1367.73 PIVOT
First Support 1335.47 First Resistance 1397.87 Second Support 1305.33 Second Resistance 1430.13 Third Support 1273.07 Third Resistance 1460.27
RSI 49.42 ADX 30.40 MACD 1.01 Williams % R -52.73 Commodity Channel Index (CCI) -22.41
Date 2026-06-11 Week 39492.00 Same Day 32563.00 Month 55607.00
1 Year 0.48 3 Year 0.47
Over 1 Month
-0.78% down
Over 1 Year
-20.38% down
Over 3 Months
1.20% down
Over 3 Years
27.43% down
Over 6 Months
-14.14% down
Over 5 Years
14.12% down

ERIS LIFESCIENCES LIMITED Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
29 May 2026 7.21 Interim 29 May 2026 Equity shares
13 Feb 2025 7.35 Interim 13 Feb 2025 Equity shares
11 Aug 2022 7.35 Interim 16 Aug 2022 Equity shares
05 Aug 2021 6.01 Interim 06 Aug 2021 Equity shares
13 Aug 2020 5.5 Interim 14 Aug 2020 Equity shares
19 Mar 2020 2.87 Interim 20 Mar 2020 Equity shares
Dividend date Dividend amount Dividend type Record date Instrument type
29 May 2026 7.21 Interim 29 May 2026 Equity shares
13 Feb 2025 7.35 Interim 13 Feb 2025 Equity shares
11 Aug 2022 7.35 Interim 16 Aug 2022 Equity shares
05 Aug 2021 6.01 Interim 06 Aug 2021 Equity shares
13 Aug 2020 5.5 Interim 14 Aug 2020 Equity shares
19 Mar 2020 2.87 Interim 20 Mar 2020 Equity shares

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of ERIS Lifesciences Ltd?

Answer Field

ERIS Lifesciences Ltd share price is for NSE ₹ 1,401.00 & for BSE ₹ 1,398.80 as on Jun 12 2026 03:29 PM.

What is the Market Cap of ERIS Lifesciences Ltd Share?

Answer Field

The market cap of ERIS Lifesciences Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jun 12 2026 03:29 PM.

What is the 52 Week High and Low of ERIS Lifesciences Ltd?

Answer Field

The 52 Week High and Low of ERIS Lifesciences Ltd for NSE is ₹ 1,910.00 and ₹ 1,200.00 and for BSE is ₹ 1,909.55 and ₹ 1,237.90.

What is 1 year return for ERIS Lifesciences Ltd?

Answer Field

The 1 year returns on the stock has been -21.57%.

What is the P/E Ratio of ERIS Lifesciences Ltd Share?

Answer Field

As on Jun 12 2026 03:29 PM the price-to-earnings (PE) ratio for ERIS Lifesciences Ltd share is 79.66.

What is the PB ratio of ERIS Lifesciences Ltd Share?

Answer Field

As on Jun 12 2026 03:29 PM, the price-to-book (PB) ratio for ERIS Lifesciences Ltd share is 230.60.

How to Buy ERIS Lifesciences Ltd Share?

Answer Field

You can trade in ERIS Lifesciences Ltd shares with Bajaj Broking by opening a demat account.

How to Buy ERIS Lifesciences Ltd Share on Bajaj Broking App?

Answer Field

To buy ERIS Lifesciences Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “ERIS Lifesciences Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|